drugset / Trial / NCT01887691
Sleep Effectiveness and Insulin and Glucose Homeostasis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the influence of sleep effectiveness on glucose and insulin metabolism in health and disease (prediabetes and type two diabetes). We will monitor sleep effectiveness using the sleep spectrogram, obtain serial nocturnal blood glucose and insulin measurements, and assess the impact of pharmacologic enhancement \[using eszopiclone (Lunesta), a medication that promotes stable sleep)\] on glucose and insulin homeostasis. We hypothesize that 1: Effective sleep is associated with enhanced insulin sensitivity, relative to ineffective sleep states, and 2: Enhancing sleep effectiveness using eszopiclone (Lunesta) improves 24-hour glucose metabolism in prediabetics and diabetics compared to baseline.
Timeline
- Start
- 2012-10
- Primary completion
- 2015-08
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 1 mg | — |
| Subject | Eszopiclone | Small molecule | 2 mg | — |
| Subject | Eszopiclone | Small molecule | 3 mg | — |